Peritoneal Carcinomatosis Extent Evaluation: Radiologic, Laparoscopic and Pathologic.
- Conditions
- Peritoneal Carcinomatosis
- Registration Number
- NCT03798132
- Lead Sponsor
- Shimaa Abdalla Ahmed
- Brief Summary
pathologically proved ovarian cancer patients that underwent contrast enhanced abdomino-pelvic CT and diagnostic laparoscopy before cytoreductive surgery (CRS) will be included in the study. Calculation of PCI (peritoneal cancer index) using Sugarbaker's method, peritoneal carcinomatosis extent will be categorized into low, moderate and large. Agreement in general and in each category between CT, laparoscopy, surgery and pathology will be assessed using kappa agreement.
- Detailed Description
we will search medical records of primary ovarian cancer patients underwent CT abdomen, laparoscopy followed by cytoreductive surgery to calculate peritoneal carcinomatosis extent by each modality.
Regional PCI was calculated in each of the 13 anatomical abdominopelvic regions, then total PCI by summation of the lesion size score, it ranged from 0 to 39. Categorization of peritoneal carcinomatosis was classified into 3 categories low if PCI \< 10, moderate if 10-20, and large if \>20.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 80
pathologically proved ovarian cancer patients underwent contrast enhanced abdominopelvic CT and diagnostic laparoscopy before cytoreductive surgery -
recurrent ovarian cancer
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method peritoneal carcinomatosis one year Agreement in general and in each category between CT, laparoscopy, surgery and pathology was assessed using kappa agreement.
- Secondary Outcome Measures
Name Time Method surgical decision making. one year correlation of peritoneal carcinomatosis categorization with surgical decision
Trial Locations
- Locations (1)
South Egypt Cancer Institute
🇪🇬Assiut, Egypt